{"success":true,"data":{"pressRelease":{"id":"108511","rtpr_id":"nPn9pMgHxa","ticker":"INO","exchange":"NASDAQ","all_tickers":["INO"],"title":"INOVIO to Report Second Quarter Financial Results on August 12, 2026","author":"PR Newswire","published_at":"2026-08-04T20:05:00.582Z","article_body":"INOVIO to Report Second Quarter Financial Results on August 12, 2026\n\nPR Newswire\n\nPLYMOUTH MEETING, Pa., Aug. 4, 2026\n\nPLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a\nbiotechnology company focused on developing and commercializing DNA medicines\nto help treat and protect people from HPV-related diseases, cancer, and\ninfectious diseases, today announced that its second quarter 2026 financial\nresults will be released after the market close on August 12th, 2026.\nFollowing the release, INOVIO will host a live conference call and webcast at\n4:30 p.m. ET to discuss the financial results and provide a general business\nupdate.\n\nThe live webcast will be available online at\nhttp://ir.inovio.com/events-and-presentations/default.aspx\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745718-1&h=1745591594&u=http%3A%2F%2Fir.inovio.com%2Fevents-and-presentations%2Fdefault.aspx&a=http%3A%2F%2Fir.inovio.com%2Fevents-and-presentations%2Fdefault.aspx)\n. This is a listen-only event but will include a live Q&A with analysts.\nThe webcast will be archived and available for replay for 90 days following\nthe event.\n\nAbout INOVIO\nINOVIO is a biotechnology company focused on developing and commercializing\ninnovative DNA medicines to help treat and protect people from HPV-related\ndiseases, cancer, and infectious diseases. INOVIO's technology optimizes the\ndesign and delivery of DNA medicines that teach the body to manufacture its\nown disease-fighting tools. For more information, visit www.inovio.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745718-1&h=2030867331&u=http%3A%2F%2Fwww.inovio.com%2F&a=www.inovio.com)\n\nContacts\nMedia: Jennie Willson, (267) 429-8567, communications@inovio.com\n(mailto:communications@inovio.com)\nInvestors: Peter Vozzo - ICR Healthcare, (443)\n213-0505, investor.relations@inovio.com\n(mailto:investor.relations@inovio.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html\n(https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html)\n\nSOURCE INOVIO Pharmaceuticals, Inc.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS653387/INOVIO-v1-Logo.jpg?id=OA2800107\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn9pMgHxa","title":"INOVIO to Report Second Quarter Financial Results on August 12, 2026","author":"PR Newswire","ticker":"INO","created":"2026-08-04T20:05:00.582Z","tickers":["INO"],"exchange":"NASDAQ","article_body":"INOVIO to Report Second Quarter Financial Results on August 12, 2026\n\nPR Newswire\n\nPLYMOUTH MEETING, Pa., Aug. 4, 2026\n\nPLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a\nbiotechnology company focused on developing and commercializing DNA medicines\nto help treat and protect people from HPV-related diseases, cancer, and\ninfectious diseases, today announced that its second quarter 2026 financial\nresults will be released after the market close on August 12th, 2026.\nFollowing the release, INOVIO will host a live conference call and webcast at\n4:30 p.m. ET to discuss the financial results and provide a general business\nupdate.\n\nThe live webcast will be available online at\nhttp://ir.inovio.com/events-and-presentations/default.aspx\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745718-1&h=1745591594&u=http%3A%2F%2Fir.inovio.com%2Fevents-and-presentations%2Fdefault.aspx&a=http%3A%2F%2Fir.inovio.com%2Fevents-and-presentations%2Fdefault.aspx)\n. This is a listen-only event but will include a live Q&A with analysts.\nThe webcast will be archived and available for replay for 90 days following\nthe event.\n\nAbout INOVIO\nINOVIO is a biotechnology company focused on developing and commercializing\ninnovative DNA medicines to help treat and protect people from HPV-related\ndiseases, cancer, and infectious diseases. INOVIO's technology optimizes the\ndesign and delivery of DNA medicines that teach the body to manufacture its\nown disease-fighting tools. For more information, visit www.inovio.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4745718-1&h=2030867331&u=http%3A%2F%2Fwww.inovio.com%2F&a=www.inovio.com)\n\nContacts\nMedia: Jennie Willson, (267) 429-8567, communications@inovio.com\n(mailto:communications@inovio.com)\nInvestors: Peter Vozzo - ICR Healthcare, (443)\n213-0505, investor.relations@inovio.com\n(mailto:investor.relations@inovio.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html\n(https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html)\n\nSOURCE INOVIO Pharmaceuticals, Inc.\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS653387/INOVIO-v1-Logo.jpg?id=OA2800107\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-04T20:05:00.821358835Z","server_sent_at_ms":1785873900821},"received_at":"2026-08-04T20:05:00.886Z","source_url":"https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html"},"analysis":{"id":"97517","press_release_id":"108511","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"operations_update","narrative":"INOVIO announced it will release its second quarter 2026 financial results after the market close on August 12, 2026.\n\nManagement will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a general business update.\n\nThe webcast will be available for replay for 90 days following the event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine earnings calendar announcement."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Jennie Willson","role":"Media Contact"},{"name":"Peter Vozzo","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"INOVIO Pharmaceuticals, Inc.","ticker":"INO"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine calendar announcement of earnings date and conference call. No financial results or material updates provided."},"tickerRelevance":{"others":[],"primary":"INO"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-mid-cap","eventGravity":"calendar-notice"}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"INOVIO announced it will release its second quarter 2026 financial results after the market close on August 12, 2026.\n\nManagement will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a general business update.\n\nThe webcast will be available for replay for 90 days following the event.","key_figures":{},"named_entities":{"people":[{"name":"Jennie Willson","role":"Media Contact"},{"name":"Peter Vozzo","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"INOVIO Pharmaceuticals, Inc.","ticker":"INO"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-05T01:14:07.481Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-mid-cap","eventGravity":"calendar-notice"}},"durationMs":345977,"modelName":"glm-4.7"}}